ResearcherUCL School of PharmacyNo recent work listed
Fanny Joubert
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 3
- Photochemical Internalization Using Natural Anticancer Drugs, Antimetabolites, and Nanoformulations: A Systematic Study against Breast and Pancreatic Cancer Ce… First author DOI 10.1021/acs.molpharmaceut.2c01012↗
- Hierarchically designed hybrid nanoparticles for combinational photochemotherapy against a pancreatic cancer cell line. Co-author DOI 10.1039/c7tb03261g↗
- Development of a Gemcitabine-Polymer Conjugate with Prolonged Cytotoxicity against a Pancreatic Cancer Cell Line. Co-author DOI 10.1021/acsmacrolett.7b00160↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- George Pasparakis · 3 shared papers, 2017–2023 · strength 0.51
- Paper Photochemical Internalization Using Natural Anticancer Drugs, Antimetabolites, and Nanoformulations: A Systematic Study… DOI 10.1021/acs.molpharmaceut.2c01012↗
- Paper Hierarchically designed hybrid nanoparticles for combinational photochemotherapy against a pancreatic cancer cell line. DOI 10.1039/c7tb03261g↗
- Paper Development of a Gemcitabine-Polymer Conjugate with Prolonged Cytotoxicity against a Pancreatic Cancer Cell Line. DOI 10.1021/acsmacrolett.7b00160↗
- Christopher Barnett · 1 shared paper, 2023 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.